8-K: Chemed Corporation Reports Strong First-Quarter 2025 Results Driven by VITAS Healthcare Growth

Chemed Corporation announces a 9.8% increase in revenue to $646.9 million for the first quarter of 2025, driven by strong performance in its VITAS Healthcare segment.

Summary

• Chemed Corporation reported its financial results for the first quarter ended March 31, 2025.
• Consolidated revenue increased by 9.8% to $646.9 million.
• GAAP Diluted Earnings-per-Share (EPS) increased by 14.6% to $4.86.
• Adjusted Diluted EPS increased by 8.3% to $5.63.
• VITAS segment net patient revenue increased by 15.1% to $407.4 million.
• VITAS' Average Daily Census (ADC) increased by 13.1% to 22,244.
• VITAS' admissions increased by 7.3% to 18,139.
• Roto-Rooter segment revenue increased by 1.8% to $239.5 million.
• During the quarter, the Company repurchased 50,000 shares of Chemed stock for $29.8 million which equates to a cost per share of $595.15.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue and earnings growth, particularly in the VITAS segment. While Roto-Rooter's performance was more modest, the overall tone is optimistic.

Positives

• Consolidated revenue increased by 9.8% to $646.9 million.
• GAAP Diluted EPS increased by 14.6% to $4.86.
• Adjusted Diluted EPS increased by 8.3% to $5.63.
• VITAS segment net patient revenue increased by 15.1% to $407.4 million.
• VITAS' Average Daily Census (ADC) increased by 13.1% to 22,244.
• VITAS' admissions increased by 7.3% to 18,139.
• Roto-Rooter branch commercial revenue increased 7.3% from the prior-year period.
• Chemed has no current or long-term debt and $173.9 million in cash and cash equivalents.
• Chemed has approximately $225.6 million of remaining share repurchase authorization under its plan.

Negatives

• Roto-Rooter segment net income decreased by 2.1% to $41.8 million.
• Roto-Rooter segment Adjusted EBITDA decreased by 2.4% to $59.2 million.
• Roto-Rooter's Adjusted EBITDA margin declined by 108-basis points to 24.7%.
• Roto-Rooter branch residential revenue in the quarter totaled $167.2 million, an increase of 1.7%, over the prior-year period.
• In the first quarter of 2025, revenue from independent contractors declined 6.4% as compared to the same period of 2024.

Risks

• Possible changes in regulations governing the hospice care or plumbing and drain cleaning industries.
• Periodic changes in reimbursement levels and procedures under Medicare and Medicaid programs.
• Difficulties predicting patient length of stay and estimating potential Medicare reimbursement obligations.
• Challenges inherent in Chemed's growth strategy.
• The current shortage of qualified nurses, other healthcare professionals and licensed plumbing and drain cleaning technicians.
• Chemed's dependence on patient referral sources.

Future Outlook

Management anticipates providing updated 2025 earnings guidance as part of the June 30, 2025 earnings press release.

Industry Context

Chemed operates in the healthcare field through its VITAS Healthcare Corporation subsidiary, providing hospice services. It also operates in the residential and commercial plumbing and drain cleaning industry under the brand name Roto-Rooter. The hospice industry is influenced by demographic trends, regulatory changes, and reimbursement policies. The plumbing and drain cleaning industry is affected by housing market conditions, infrastructure spending, and consumer spending patterns.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• To assess Chemed's performance relative to its peers, one would need to compare its growth rates, profitability margins, and key operating metrics (e.g., ADC for VITAS, revenue per employee for Roto-Rooter) against those of companies like Amedisys (hospice) and publicly traded plumbing service companies.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and share repurchase program.
• Employees at VITAS may benefit from the company's growth and expansion.
• Customers of VITAS will continue to receive end-of-life care services.
• Customers of Roto-Rooter will continue to receive plumbing and drain cleaning services.

Next Steps

• Chemed will host a conference call and webcast on April 24, 2025, to discuss the quarterly results.
• Management will provide updated 2025 earnings guidance as part of the June 30, 2025 earnings press release.

Key Dates

Keywords

Chemed, VITAS Healthcare, Roto-Rooter, Financial Results, Hospice Care, Plumbing, Drain Cleaning, Revenue, Earnings, EBITDA